BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23452274)

  • 1. Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients.
    Reich-Slotky R; Andrews J; Cheng B; Buchsbaum R; Levy D; Kaufmann P; Thompson JL
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):212-6. PubMed ID: 23452274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
    Park Y; Park J; Kim Y; Baek H; Kim SH
    Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
    Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
    Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
    Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
    Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
    Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
    J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
    Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 10-metre gait speed as a functional biomarker in amyotrophic lateral sclerosis.
    Inam S; Vucic S; Brodaty NE; Zoing MC; Kiernan MC
    Amyotroph Lateral Scler; 2010 Dec; 11(6):558-61. PubMed ID: 20515425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RandomForest4Life: a Random Forest for predicting ALS disease progression.
    Hothorn T; Jung HH
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):444-52. PubMed ID: 25141076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
    Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
    No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients.
    Watanabe H; Atsuta N; Nakamura R; Hirakawa A; Watanabe H; Ito M; Senda J; Katsuno M; Izumi Y; Morita M; Tomiyama H; Taniguchi A; Aiba I; Abe K; Mizoguchi K; Oda M; Kano O; Okamoto K; Kuwabara S; Hasegawa K; Imai T; Aoki M; Tsuji S; Nakano I; Kaji R; Sobue G
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):230-6. PubMed ID: 25548957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance in the change of decline in ALSFRS-R.
    Castrillo-Viguera C; Grasso DL; Simpson E; Shefner J; Cudkowicz ME
    Amyotroph Lateral Scler; 2010; 11(1-2):178-80. PubMed ID: 19634063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis.
    Rooney J; Burke T; Vajda A; Heverin M; Hardiman O
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial.
    Kaufmann P; Levy G; Montes J; Buchsbaum R; Barsdorf AI; Battista V; Arbing R; Gordon PH; Mitsumoto H; Levin B; Thompson JL;
    Amyotroph Lateral Scler; 2007 Feb; 8(1):42-6. PubMed ID: 17364435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diaphragmatic CMAP amplitude from phrenic nerve stimulation predicts functional decline in ALS.
    Miranda B; Gromicho M; Pereira M; Pinto S; Swash M; de Carvalho M
    J Neurol; 2020 Jul; 267(7):2123-2129. PubMed ID: 32253508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials.
    Daghlas I; Lever TE; Leary E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):206-211. PubMed ID: 29260911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
    Kimura F; Fujimura C; Ishida S; Nakajima H; Furutama D; Uehara H; Shinoda K; Sugino M; Hanafusa T
    Neurology; 2006 Jan; 66(2):265-7. PubMed ID: 16434671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression in ALS is not linear but is curvilinear.
    Gordon PH; Cheng B; Salachas F; Pradat PF; Bruneteau G; Corcia P; Lacomblez L; Meininger V
    J Neurol; 2010 Oct; 257(10):1713-7. PubMed ID: 20532545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination Rate of Serum Lactate is Correlated with Amyotrophic Lateral Sclerosis Progression.
    Zhang YJ; Fan DS
    Chin Med J (Engl); 2016 Jan; 129(1):28-32. PubMed ID: 26712429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
    Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.